Neonatal Diabetes and the KATP Channel: From Mutation to Therapy.

Abstract excerpt

Activating mutations in one of the two subunits of the ATP-sensitive potassium (KATP) channel cause neonatal diabetes (ND). This may be either transient or permanent and, in approximately 20% of patients, is associated with neurodevelopmental delay. In most patients, switching from insulin to oral sulfonylurea therapy improves glycemic control and ameliorates some of the neurological disabilities. Here, we review...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Blood Glucose
• Share to Diabetes Mellitus
• Share to Hypoglycemic Agents